These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 986033)

  • 41. McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases.
    Bartram C; Edwards RH; Clague J; Beynon RJ
    Hum Mol Genet; 1993 Aug; 2(8):1291-3. PubMed ID: 8401511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lactate production in McArdle's disease.
    Baksi AK; Buxton PH; Cochrane P; Hughes RR
    Postgrad Med J; 1977 Mar; 53(617):161-4. PubMed ID: 266169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myophosphorylase deficiency: two different molecular etiologies.
    Feit H; Brooke MH
    Neurology; 1976 Oct; 26(10):963-7. PubMed ID: 1066528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [McArdle's disease in a 14-year-old girl with fatigability and raised muscle enzymes].
    López-Pisón J; Muñoz-Albillos MS; Boudet-García A; Giménez-Más JA; Peña-Segura JL; Abenia-Usón P
    Rev Neurol; 2000 May 16-31; 30(10):932-4. PubMed ID: 10919189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new variant of late-onset myophosphorylase deficiency.
    Kost GJ; Verity MA
    Muscle Nerve; 1980; 3(3):195-201. PubMed ID: 6929403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic fatigue and myalgia syndrome: mitochondrial and glycolytic studies in skeletal muscle.
    Byrne E; Trounce I
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):743-6. PubMed ID: 3039060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
    Tsujino S; Shanske S; DiMauro S
    N Engl J Med; 1993 Jul; 329(4):241-5. PubMed ID: 8316268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [McArdle disease: differential diagnosis of the increase in creatine kinase induced by the exercise test].
    Frick E; Reutter FW; Weder B
    Schweiz Med Wochenschr; 1988 Dec; 118(52):1993-6. PubMed ID: 3217781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease.
    Mineo I; Kono N; Yamada Y; Hara N; Kiyokawa H; Hamaguchi T; Kawachi M; Yamasaki T; Nakajima H; Kuwajima M
    Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amino acid metabolism during exercise in McArdle's syndrome: evidence of altered alanine metabolism.
    Felig P; Havel RJ; Jorfeldt L; Pernow B; Saltin B; Wahren J
    J Physiol; 1972 Dec; 227(2):33P-35P. PubMed ID: 4509618
    [No Abstract]   [Full Text] [Related]  

  • 51. Myophosphorylase B deficiency and malignant hyperthermia.
    Isaacs H; Badenhorst ME; Du Sautoy C
    Muscle Nerve; 1989 Mar; 12(3):203-5. PubMed ID: 2498654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2,4-Dinitrophenol, muscle biopsy, and McArdle's disease.
    Heller SL; Brooke MH; Kaiser KK; Choski R
    Neurology; 1988 Jan; 38(1):15-9. PubMed ID: 3422109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise.
    Jehenson P; Leroy-Willig A; de Kerviler E; Duboc D; Syrota A
    AJR Am J Roentgenol; 1993 Aug; 161(2):347-51. PubMed ID: 8333376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Muscle glycogen phosphorylase deficiency.
    Moses SW
    Isr J Med Sci; 1989 Feb; 25(2):61-3. PubMed ID: 2703327
    [No Abstract]   [Full Text] [Related]  

  • 55. Hereditary absence of muscle phosphorylase (McArdle's syndrome).
    SCHMID R; HAMMAKER L
    N Engl J Med; 1961 Feb; 264():223-5. PubMed ID: 13747935
    [No Abstract]   [Full Text] [Related]  

  • 56. Exercise intolerance in patients with McArdle's disease or mitochondrial myopathies.
    Chaussain M; Camus F; Defoligny C; Eymard B; Fardeau M
    Eur J Med; 1992 Dec; 1(8):457-63. PubMed ID: 1341204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fatal infantile form of muscle phosphorylase deficiency.
    DiMauro S; Hartlage PL
    Neurology; 1978 Nov; 28(11):1124-9. PubMed ID: 101896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ATP degradation products after ischemic exercise: hereditary lack of phosphorylase or carnitine palmityltransferase.
    Bertorini TE; Shively V; Taylor B; Palmieri GM; Fox IH
    Neurology; 1985 Sep; 35(9):1355-7. PubMed ID: 3860749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease.
    De Stefano N; Argov Z; Matthews PM; Karpati G; Arnold DL
    Muscle Nerve; 1996 Jun; 19(6):764-9. PubMed ID: 8609928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myophosphorylase deficiency: an unusually severe form with myoglobinuria.
    Kristjánsson K; Tsujino S; DiMauro S
    J Pediatr; 1994 Sep; 125(3):409-10. PubMed ID: 8071750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.